Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin Phosphate Patent Expiration


About Veterinary Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin Phosphate

Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin Phosphate is used in drugs marketed by 3 different companies: Huvepharma Eood, Phibro Animal Health Corp, Elanco Us Inc.

Other drugs containing Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin Phosphate are: Optaflexx and rumensin and tylanand mga , Optaflexx and monovet and tylovet and mga , Optaflexx 45/rumensin/tylovet 100/mga , Heifermax / optaflexx / rumensin / tylan

Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin Phosphate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin Phosphate Generic API Manufacturers

Given below is the list of companies who have filed for Melengestrol Acetate, Monensin, Ractopamine Hydrochloride, Tylosin Phosphate generic, along with the locations of their manufacturing plants worldwide.